Kingworld Medicines Group Ltd

HKSE:01110 (China)  
HK$ 0.62 (+8.77%) May 17
8.45
P/B:
0.55
Market Cap:
HK$ 385.95M ($ 49.47M)
Enterprise V:
HK$ 559.42M ($ 71.70M)
Volume:
1.16M
Avg Vol (2M):
639.89K
Volume:
1.16M
Avg Vol (2M):
639.89K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Kingworld Medicines Group Ltd ( HKSE:01110 ) from 2000 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kingworld Medicines Group stock (HKSE:01110) PE ratio as of May 17 2024 is 8.45. More Details

Kingworld Medicines Group Ltd (HKSE:01110) PE Ratio (TTM) Chart

To

Kingworld Medicines Group Ltd (HKSE:01110) PE Ratio (TTM) Historical Data

Total 1208
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Kingworld Medicines Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-18 8.7 2024-03-11 8.3
2024-05-17 8.7 2024-03-08 7.9
2024-05-16 8.0 2024-03-07 8.2
2024-05-14 8.2 2024-03-06 8.3
2024-05-13 7.9 2024-03-05 7.9
2024-05-10 8.2 2024-03-04 8.2
2024-05-09 7.8 2024-03-01 7.9
2024-05-08 7.9 2024-02-29 7.9
2024-05-07 7.5 2024-02-28 8.0
2024-05-06 7.9 2024-02-27 8.2
2024-05-03 7.5 2024-02-26 8.0
2024-05-02 7.5 2024-02-23 8.0
2024-04-30 7.8 2024-02-22 7.5
2024-04-29 7.6 2024-02-21 7.8
2024-04-26 7.6 2024-02-20 7.6
2024-04-25 7.5 2024-02-19 7.6
2024-04-24 7.0 2024-02-16 7.6
2024-04-23 7.0 2024-02-15 7.6
2024-04-22 7.0 2024-02-14 7.6
2024-04-19 7.0 2024-02-09 7.6
2024-04-18 7.2 2024-02-08 7.9
2024-04-17 7.2 2024-02-07 7.9
2024-04-16 7.0 2024-02-06 8.0
2024-04-15 7.0 2024-02-05 8.2
2024-04-12 7.0 2024-02-02 8.2
2024-04-11 7.0 2024-02-01 8.2
2024-04-10 7.0 2024-01-31 8.2
2024-04-09 7.3 2024-01-30 8.2
2024-04-08 7.3 2024-01-29 8.3
2024-04-05 7.3 2024-01-26 8.4
2024-04-03 7.3 2024-01-25 8.7
2024-04-02 7.3 2024-01-24 8.7
2024-03-28 7.3 2024-01-23 8.9
2024-03-27 7.5 2024-01-22 8.0
2024-03-26 7.6 2024-01-19 8.3
2024-03-25 8.7 2024-01-18 8.3
2024-03-22 7.5 2024-01-17 8.6
2024-03-21 7.9 2024-01-16 8.6
2024-03-20 7.6 2024-01-15 8.4
2024-03-19 7.8 2024-01-12 8.4
2024-03-18 8.3 2024-01-11 8.4
2024-03-15 8.4 2024-01-10 8.9
2024-03-14 8.6 2024-01-09 9.0
2024-03-13 8.0 2024-01-08 9.0
2024-03-12 8.3 2024-01-05 8.9

Kingworld Medicines Group Ltd (HKSE:01110) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.